Paul Emery, MD, FRCP - Long-Term Efficacy of Newer Biologics in Refractory Rheumatoid Arthritis
Summary: In this activity, experts in the treatment of rheumatoid arthritis discuss recent data on the use of abatacept and rituximab in methotrexate- or TNF-antagonist-refractory rheumatoid arthritis.